Also called personalized medicine, this evolving field makes use of an individual’s genes, lifestyle, environment and other factors to identify unique disease risks and guide treatment decision-making.
Masimo's MightySat Medical is the first FDA-cleared pulse oximeter available to consumers without a prescription, which could disrupt the market for the notoriously inaccurate at-home devices.
MediView’s technologies utilize AR to provide clinicians with 3D “X-ray vision” guidance during minimally invasive procedures and surgeries, while also offering remote collaboration.
The vast majority of healthcare executives––89%––are experimenting with emerging technologies such as AI, according to Accenture’s Digital Health Technology Vision report.
Using a deep neural network equipped with all patient information relevant to diagnosing adult asthma, researchers in Japan have achieved 98% diagnostic accuracy.
Hoping to encourage interdisciplinary collaboration around Big Data over the next 50 to 100 years, Boston University is preparing to build a 17-story architectural marvel.
Facial recognition technology can be used to monitor sedated patients in intensive care units, alerting healthcare workers when a patient is at risk of accidentally removing a breathing tube or engaging in other risky behavior.
AI continues to wow healthcare watchers with sharp guidance on clinical decisionmaking, accurate aids to risk assessment and bankable workflow efficiencies. But healthcare was, is and always will be about “human-to-human relationships, trust and healing.”
Researchers in Texas and Taiwan have collaborated to develop a deep-learning tool that can precisely asses the risk of breast cancer—and with it the need for biopsy—in patients with lesions of questionable concern found in mammograms.
Diagnosing coronary artery disease, the most common type of heart disease in the U.S., can be improved by AI, according to a new, multicenter international study published in The Journal of Nuclear Medicine.
A healthcare AI startup striving to become the biggest provider of virtual medicine in India has gotten a boost in the form of investor dollars and friendly coverage in a prominent business journal.
Compensation for heart specialists continues to climb. What does this say about cardiology as a whole? Could private equity's rising influence bring about change? We spoke to MedAxiom CEO Jerry Blackwell, MD, MBA, a veteran cardiologist himself, to learn more.
The American College of Cardiology has shared its perspective on new CMS payment policies, highlighting revenue concerns while providing key details for cardiologists and other cardiology professionals.
As debate simmers over how best to regulate AI, experts continue to offer guidance on where to start, how to proceed and what to emphasize. A new resource models its recommendations on what its authors call the “SETO Loop.”
